Carregant...
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists of a maximum of six cycles of platinum-based doublet chemotherapy followed by surveillance for disease progression. Recently, the strategy of starting second-line treatment immediately following the completion...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3042878/ https://ncbi.nlm.nih.gov/pubmed/21142856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.10.156 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|